Clinical Trials
- This forum has 759 topics, 1,631 replies, and was last updated 2 years, 4 months ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
-
Our New Discussion Board is HERE
1
2
3
Started by:
in: Announcements
- 17
- 31
- 2 years, 10 months ago
- INCB 54828 1 2 … 4 5
- 14
- 63
- 5 years, 8 months ago
- Update on NIH Trial 1 2 … 6 7
- 20
- 93
- 7 years, 2 months ago
- Agios to Present Clinical Data from Ongoing AG-120 Phase 1 Trial 1 2 … 6 7
- 15
- 98
- 7 years, 6 months ago
- First-in-man histotripsy of hepatic tumors: the THERESA trial, a feasibility stu
- 1
- 1
- 2 years, 4 months ago
- Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemci
- 1
- 1
- 2 years, 4 months ago
- Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization Combin
- 1
- 1
- 2 years, 5 months ago
- A phase Ib, open-label, multi-cohort study of metronomic capecitabine plus camre
- 1
- 1
- 2 years, 6 months ago
- A phase 1b/2, dose-escalation, randomized, multicenter study of maintenance (mai
- 1
- 1
- 2 years, 6 months ago
- Design and rationale of a first-in-human (FIH) phase 1/1b study evaluating KIN-3
- 1
- 1
- 2 years, 6 months ago
- Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in
- 1
- 1
- 2 years, 6 months ago
- Study protocol of an open-label, single-arm, phase II trial investigating the ef
- 1
- 1
- 2 years, 6 months ago
- Pemigatinib in Chinese patients with advanced/metastatic or surgically unresecta
- 1
- 1
- 2 years, 6 months ago
- Multicentre match-paired analysis of advanced biliary cancer long-term survivors
- 1
- 1
- 2 years, 7 months ago
- TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial, Studyin
- 1
- 1
- 2 years, 7 months ago
- Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK
- 1
- 1
- 2 years, 7 months ago
- Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP S
- 1
- 1
- 2 years, 9 months ago
-
Our New Discussion Board is HERE
1
2
3
- The forum ‘Clinical Trials’ is closed to new topics and replies.